HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of prenylamine on the QT interval of the resting electrocardiogram in patients with angina pectoris.

Abstract
Resting ECGs were recorded in 29 patients with angina pectoris before, during and after treatment with prenylamine 180 mg daily. The QT interval became significantly prolonged after one week of treatment. The prolongation persisted as long as therapy was continued, which was up to 6 months. After withdrawal of treatment the QT interval returned to normal within 2 weeks. In this study no serious problems were encountered by those patients in whom the QT interval was prolonged.
AuthorsD Oakley, K Jennings, R Puritz, D Krikler, D Chamberlain
JournalPostgraduate medical journal (Postgrad Med J) Vol. 56 Issue 661 Pg. 753-6 (Nov 1980) ISSN: 0032-5473 [Print] England
PMID7267475 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Prenylamine
Topics
  • Adult
  • Aged
  • Angina Pectoris (drug therapy, physiopathology)
  • Electrocardiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prenylamine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: